Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation

Guido A Gualdoni1, Tilman Lingscheid2, Klaus G Schmetterer3

  • 1Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Scientific Reports
|July 9, 2015
PubMed

Insights

Azithromycin, but not other macrolides, inhibits inflammasome activation by accumulating intracellularly. This finding is relevant for treating inflammatory diseases like COPD and asthma.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Inflammasome activation deregulation is implicated in inflammatory diseases.
  • Macrolide antibiotics have known immunomodulatory effects, but their impact on inflammasomes is unclear.

Purpose of the Study:

  • To investigate the differential effects of macrolides on inflammasome activation.
  • To explore the mechanisms underlying azithromycin's immunomodulatory properties.

Main Methods:

  • Comparing macrolide influence on cytokine induction in human monocytes.
  • Examining intracellular azithromycin accumulation via Ca(++)-dependent uptake.
  • Analyzing inflammasome signaling cascades and validating findings in a murine sepsis model.

Main Results:

  • Azithromycin, unlike clarithromycin and roxithromycin, inhibited IL-1α and IL-1β secretion induced by LPS.
  • Inhibition of cytokine release by azithromycin required Ca(++)-dependent intracellular accumulation.
  • Azithromycin specifically inhibited LPS-induced caspase-4 activation, not flagellin-induced activation, and reduced IL-1β in a murine sepsis model.

Conclusions:

  • Macrolides exhibit differential effects on the inflammasome/IL-1β axis.
  • Intracellular azithromycin accumulation is key to its inflammasome-modulatory effects.
  • Findings suggest potential therapeutic applications for azithromycin in inflammasome-driven diseases.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
775
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
56
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
698